ClinicalTrials.gg
CompletedNCT07290075Updated Dec 17, 2025

The Relationship Between Olfactory and Gustatory Senses, Hedonic Hunger, and Diet Quality After Bariatric Surgery

An observational study in Obesity, Taste Disorders and Smell Disorder, sponsored by Hanife Köksal. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-12-17.

Sponsored by Hanife Köksal · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
101
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This cross-sectional observational study investigates the association between changes in olfactory and gustatory senses and hedonic hunger among individuals who have undergone bariatric surgery. The study also examines the effects of these sensory changes on diet quality and anthropometric measurements. Participants completed a structured questionnaire including sociodemographic and health information, dietary habits, a modified 33-item taste and smell assessment, the Power of Food Scale (PFS), the Mediterranean Diet Adherence Screener (MEDAS), the International Physical Activity Questionnaire (IPAQ), and anthropometric measurements.

Read the detailed description

Obesity is a chronic, multifactorial disease that negatively impacts health and quality of life. Bariatric surgery is an effective treatment option for severe obesity, leading to significant and sustained weight loss as well as improvement in obesity-related comorbidities.

Postoperative changes in taste and smell perception are frequently reported by bariatric patients and may influence food preferences, hedonic hunger, and overall diet quality. These sensory alterations can result from anatomical and hormonal changes after surgery, including altered gut hormone secretion (e.g., PYY, GLP-1, ghrelin) and bile acid metabolism, which affect appetite regulation and reward pathways.

This cross-sectional observational study evaluated adults aged 18-65 years who had undergone sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least three months prior to enrollment. Data collection included sociodemographic and health information, dietary habits, a modified 33-item taste and smell questionnaire, the Power of Food Scale (PFS) to assess hedonic hunger, the Mediterranean Diet Adherence Screener (MEDAS), the International Physical Activity Questionnaire (IPAQ), and anthropometric measurements. Nutrient intakes were analyzed according to the Türkiye Nutrition Guide (TÜBER-2022) reference values.

The primary objective was to determine the relationship between postoperative taste/smell changes and hedonic hunger. Secondary objectives included assessing the association between sensory perception and Mediterranean diet adherence, anthropometric parameters, and nutrient adequacy by surgery type. Findings from this study may guide the development of personalized nutritional follow-up protocols to improve long-term outcomes in bariatric patients.

02

Conditions studied

  • Obesity
  • Taste Disorders
  • Smell Disorder

Keywords

  • Hedonic Hunger
  • bariatric surgery outcomes
  • Mediterranean Diet
  • Nutrient Adequacy
  • Power of Food Scale (PFS)
  • Taste and Smell Questionnaire
  • MEDAS
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's enrollment of 101 is below the median of 114 across 2,154 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

This is the only study on the registry with Hanife Köksal as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 18-65 years who have undergone bariatric surgery (Sleeve Gastrectomy or Roux-en-Y Gastric Bypass) at least 3 months prior to enrollment, recruited from patients followed in clinical nutrition and bariatric surgery outpatient clinics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 65 years
  • History of bariatric surgery (Sleeve Gastrectomy or Roux-en-Y Gastric Bypass)
  • At least 3 months post-surgery at the time of study enrollment
  • Able and willing to provide

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • History of neurological disorders affecting taste or smell
  • Active upper respiratory infection at the time of assessment
  • Severe psychiatric disorders that may impair participation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
101 participants (actual)
Patient registry
No

Groups and cohorts

  • Sleeve Gastrectomy (SG)

    Participants who underwent sleeve gastrectomy at least 3 months prior to enrollment.

    Other: Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB)

  • Roux-en-Y Gastric Bypass (RYGB)

    Participants who underwent Roux-en-Y gastric bypass at least 3 months prior to enrollment.

    Other: Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB)

Interventions

  • OtherSleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB)

    Participants who have undergone sleeve gastrectomy ≥3 months prior to study enrollment; and Participants who have undergone Roux-en-Y gastric bypass ≥3 months prior to study enrollment.

06

What researchers measure

Primary outcomes

  1. Power of Food Scale (PFS) Score

    Hedonic hunger assessed using the Power of Food Scale (range: 1-5; higher scores indicate greater hedonic hunger).

    Time frame: Baseline (Day 1, at study enrollment)

  2. Modified 33-item Taste and Smell Questionnaire Score

    Changes in taste and smell perception assessed using a modified 33-item questionnaire (range: 0-33; higher scores indicate more pronounced sensory changes).

    Time frame: Baseline (≥3 months after bariatric surgery, at study enrollment)

Secondary outcomes

  1. Mediterranean Diet Adherence Screener (MEDAS) Score

    Adherence to the Mediterranean diet assessed using the 14-item MEDAS questionnaire (range: 0-14; higher scores indicate greater adherence).

    Time frame: Baseline (≥3 months after bariatric surgery, at study enrollment)

  2. Body Mass Index (BMI)

    BMI calculated as weight (kg) / height (m²).

    Time frame: Baseline (Day 1, at study enrollment)

  3. Waist-to-Hip Ratio (WHR)

    WHR calculated as waist circumference (cm) / hip circumference (cm).

    Time frame: Baseline (Day 1, at study enrollment)

  4. Energy Intake Adequacy (% of TÜBER-2022 reference)

    Daily energy intake adequacy compared to TÜBER-2022 reference values.

    Time frame: Baseline (Day 1, at study enrollment)

  5. Protein Intake Adequacy (% of TÜBER-2022 reference)

    Daily protein intake adequacy compared to TÜBER-2022 reference values.

    Time frame: Baseline (Day 1, at study enrollment)

  6. Micronutrient Intake Adequacy (e.g., iron, folate, vitamin E; % of TÜBER-2022 reference)

    Micronutrient intake adequacy compared to TÜBER-2022 reference values.

    Time frame: Baseline (Day 1, at study enrollment)

  7. Nutrient Adequacy Score (based on TÜBER-2022 reference values)

    Composite score reflecting the percentage adequacy of daily energy, macronutrient, and micronutrient intakes compared to TÜBER-2022 reference values. Higher scores indicate greater adequacy.

    Time frame: Baseline (Day 1, at study enrollment)

07

Study locations

1 site
  • Istanbul University, Faculty of Medicine, Department of Endocrinology and Metabolism
    Istanbul, Capa 34093, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — No - Individual participant data (IPD) will not be shared due to privacy concerns and lack of prior consent for public data sharing from study participants. Only aggregated results will be available in publications.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in Nov 2024, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2025
First posted
Dec 17, 2025
StartActual
Jan 1, 2024
Primary completionActual
Nov 30, 2024
CompletionActual
Jan 31, 2025
Last update
Dec 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07290075
Lead sponsor
Hanife Köksal
Collaborators
Uskudar University
Responsible party
Hanife Köksal (Registered dietitians, Istanbul University) — Sponsor-investigator
First posted
Dec 17, 2025
Start date
Jan 1, 2024
Primary completion
Nov 30, 2024
Completion
Jan 31, 2025
Last update
Dec 17, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion